Publications

Tuberculosis in children treated with second-line drugs under programmatic conditions in Lima, Peru.

Villarreal, J; Alarcón, V; Alarcón-Arrascue, E; MOORE, DA J; Heldal, E; Mendoza-Ticona, A;

2018

The international journal of tuberculosis and lung disease, (2018).22 11 10.5588/ijtld.17.0911.

Author Correction: Genome-wide analysis of multi- and extensively drug-resistant Mycobacterium tuberculosis.

COLL, F; PHELAN, J; Hill-Cawthorne, GA; Nair, MB; Mallard, K; Ali, S; Abdallah, AM; Alghamdi, S; Alsomali, M; Ahmed, AO; Portelli, S; OPPONG, Y; Alves, A; Bessa, TB; CAMPINO, S; Caws, M; Chatterjee, A; CRAMPIN, AC; DHEDA, K; FURNHAM, N; GLYNN, JR; Grandjean, L; Ha, DM; Hasan, R; Hasan, Z; ... CLARK, TG.

2018

Nature genetics, (2018).50 5 10.1038/s41588-018-0074-3.

Biomarkers for diagnosis of childhood tuberculosis: A systematic review.

TOGUN, TO; MacLean, E; KAMPMANN, B; Pai, M;

2018

PloS one, (2018).13 9 10.1371/journal.pone.0204029.

Examining human paragonimiasis as a differential diagnosis to tuberculosis in The Gambia.

Morter, R; ADETIFA, I; ANTONIO, M; TOURAY, F; De Jong, BC; Gower, CM; Gehre, F;

2018

BMC research notes, (2018).11 1 10.1186/s13104-018-3134-y.

"Treatment is of primary importance, and social assistance is secondary": A qualitative study on the organisation of tuberculosis (TB) care and patients' experience of starting and staying on TB treatment in Riga, Latvia.

Kielmann, K; Vidal, N; Riekstina, V; Krutikov, M; Van der Werf, MJ; Biraua, E; Duric, P; MOORE, DA J;

2018

PloS one, (2018).13 10 10.1371/journal.pone.0203937.

Evaluating UK National Guidance for Screening of Children for Tuberculosis. A Prospective Multicenter Study.

KAMPMANN, B; Seddon, JA; Paton, J; Nademi, Z; Keane, D; Williams, B; Williams, A; Liebeschutz, S; Riddell, A; Bernatoniene, J; Patel, S; Martinez, N; McMaster, P; Basu-Roy, R; Welch, SB;

2018

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, (2018).197 8 10.1164/rccm.201707-1487OC.

Measuring income for catastrophic cost estimates: Limitations and policy implications of current approaches.

SWEENEY, S; Mukora, R; Candfield, S; GUINNESS, L; GRANT, AD; VASSALL, A;

2018

Social science & medicine (1982), (2018).215, 10.1016/j.socscimed.2018.08.041.

Hepcidin deficiency and iron deficiency do not alter tuberculosis susceptibility in a murine M.tb infection model.

Harrington-Kandt, R; Stylianou, E; Eddowes, LA; Lim, PJ; STOCKDALE, L; Pinpathomrat, N; BULL, N; Pasricha, J; Ulaszewska, M; Beglov, Y; Vaulont, S; Drakesmith, H; McShane, H;

2018

PloS one, (2018).13 1 10.1371/journal.pone.0191038.

Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing.

CRyPTIC Consortium and the 100,000 Genomes Project,; Allix-Béguec, C; Arandjelovic, I; Bi, L; Beckert, P; Bonnet, M; Bradley, P; Cabibbe, AM; Cancino-Muñoz, I; Caulfield, MJ; Chaiprasert, A; Cirillo, DM; Clifton, DA; Comas, I; Crook, DW; De Filippo, MR; De Neeling, H; Diel, R; Drobniewski, FA; Faksri, K; Farhat, MR; Fleming, J; Fowler, P; Fowler, TA; Gao, Q; ... Zhu, B.

2018

New England Journal of Medicine, (2018).379 15 10.1056/NEJMoa1800474.

A Serum Circulating miRNA Signature for Short-Term Risk of Progression to Active Tuberculosis Among Household Contacts.

Duffy, FJ; Thompson, E; Downing, K; Suliman, S; Mayanja-Kizza, H; Boom, WH; Thiel, B; Weiner Iii, J; Kaufmann, SH E; Dover, D; Tabb, DL; DOCKRELL, HM; Ottenhoff, TH M; Tromp, G; Scriba, TJ; Zak, DE; Walzl, G; GC6-74 Consortium,;

2018

Frontiers in immunology, (2018).9 APR 10.3389/fimmu.2018.00661.